Hinge Health Rises on NYSE Debut After Pricing IPO at Top of Range

Benzinga

Hinge Health shares rose in their New York Stock Exchange debut on Thursday, according to The Wall Street Journal. Shares opened at $39.25 after pricing its IPO at $32 per share, the top of its estimated range. The company sold 8.52 million shares, with the remainder offered by existing investors, including Insight Partners and Atomico. MNTN shares surged 50% to $24 in their Thursday debut after pricing its 11.7 million-share IPO at $16, the high end of its expected range. eToro Group and Aspen Insurance both upsized their IPOs this month, with eToro pricing above its expected range and Aspen pricing in the middle. Several blank-check companies also launched with larger-than-expected IPOs.

Transcript

00:00It's Benzinga bringing Wall Street to Main Street.

00:02Hinge Health shares rose with their New York Stock Exchange debut on Thursday,

00:06according to the Wall Street Journal.

00:07Shares opened at $39.25 after pricing its IPO at $32 per share, top its estimated range.

00:14Companies sold 8.52 million shares, with the remainder offered by existing investors,

00:19including Insight Partners and Atomica.

00:22MNTN shares surged 50% to $24 in their Thursday debut

00:26after pricing its 11.7 million share IPO at $16, high end of its expected range.

00:32eToro Group and Aspen Insurance both upsized their IPOs this month,

00:36with eToro pricing above its expected range and Aspen pricing in the middle.

00:40Several blade-checked companies also launched with larger-than-expected IPOs.

00:43For all things money, visit Benzinga.com slash GSTV.

Category

Transcript

Comments

Recommended